Risk factors for reactivation of clinical disease activity...

  • Main
  • 2019 / 11
  • Risk factors for reactivation of clinical disease activity...
Multiple Sclerosis and Related Disorders 2019 / 11

Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation

Tiina, Mustonen, Ilkka, Rauma, Päivi, Hartikainen, Johanna, Krüger, Marja, Niiranen, Tuomas, Selander, Sakari, Simula, Remes, Anne M., Hanna, Kuusisto
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2019.101498
Date:
November, 2019
File:
PDF, 599 KB
english, 2019
Conversion to is in progress
Conversion to is failed